美股A股
StockGist
Back
8-K2026-02-17· grok-4-1-fast-non-reasoning

MED · Medifast, Inc.

0001628280-26-008641

SEC filing

Summary

Medifast, Inc. reported Q4 2025 revenue of $75.1 million and net loss of $18.1 million including a $12.1 million non-cash valuation allowance, with full year 2025 revenue of $385.8 million and net loss of $18.7 million. The company provided Q1 and full year 2026 guidance and highlighted a strong balance sheet with $167.3 million in cash and no debt.

Key takeaways